BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 21884356)

  • 21. A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer.
    Crawford ED; Black L; Eaddy M; Kruep EJ
    Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):162-7. PubMed ID: 20125121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer.
    Penson DF; Chan JM;
    J Urol; 2007 Jun; 177(6):2020-9. PubMed ID: 17509282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient time costs associated with cancer care.
    Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
    J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
    Tunis SL; Willis WD; Foos V
    Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost of obesity in Canada.
    Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
    CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020.
    Yabroff KR; Mariotto AB; Feuer E; Brown ML
    Health Econ; 2008 Aug; 17(8):947-59. PubMed ID: 17910108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating the cost of epilepsy in Europe: a review with economic modeling.
    Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
    Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost of diabetes in Latin America and the Caribbean.
    Barceló A; Aedo C; Rajpathak S; Robles S
    Bull World Health Organ; 2003; 81(1):19-27. PubMed ID: 12640472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
    Chevalier J; Bonastre J; Avril MF
    Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The economic burden of prostate cancer. A systematic literature overview of registry-based studies].
    Rencz F; Brodszky V; Varga P; Gajdácsi J; Nyirády P; Gulácsi L
    Orv Hetil; 2014 Mar; 155(13):509-20. PubMed ID: 24659744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-year costs of treating prostate cancer: estimates from SEER-Medicare data.
    Roehrborn CG; Albertsen P; Stokes ME; Black L; Benedict A
    Prostate Cancer Prostatic Dis; 2009; 12(4):355-60. PubMed ID: 19468284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
    Poon I; Pintilie M; Potvin M; McGowan T
    Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The economic burden of prostate cancer survivorship care.
    Skolarus TA; Zhang Y; Miller DC; Wei JT; Hollenbeck BK
    J Urol; 2010 Aug; 184(2):532-8. PubMed ID: 20620413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data.
    Stokes ME; Black L; Benedict A; Roehrborn CG; Albertsen P
    Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):278-84. PubMed ID: 20212521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of hospital utilization: the situation in Israel and selected countries.
    Benbassat J; Haklai Z; Glick S; Friedman N
    Isr Med Assoc J; 2000 Nov; 2(11):833-7. PubMed ID: 11344753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.